Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing

Keith D. Coon, Jon Valla, Szabolics Szelinger, Lonnie E. Schneider, Tracy L. Niedzielko, Kevin M. Brown, John V. Pearson, Rebecca Halperin, Travis Dunckley, Andreas Papassotiropoulos, Richard J. Caselli, Eric M. Reiman, Dietrich A. Stephan

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD) has been well documented. Though evidence for the role of mitochondria in AD seems incontrovertible, the impact of mitochondrial DNA (mtDNA) mutations in AD etiology remains controversial. Though mutations in mitochondrially encoded genes have repeatedly been implicated in the pathogenesis of AD, many of these studies have been plagued by lack of replication as well as potential contamination of nuclear-encoded mitochondrial pseudogenes. To assess the role of mtDNA mutations in the pathogenesis of AD, while avoiding the pitfalls of nuclear-encoded mitochondrial pseudogenes encountered in previous investigations and showcasing the benefits of a novel resequencing technology, we sequenced the entire coding region (15,452 bp) of mtDNA from 19 extremely well-characterized AD patients and 18 age-matched, unaffected controls utilizing a new, reliable, high-throughput array-based resequencing technique, the Human MitoChip. High-throughput, array-based DNA resequencing of the entire mtDNA coding region from platelets of 37 subjects revealed the presence of 208 loci displaying a total of 917 sequence variants. There were no statistically significant differences in overall mutational burden between cases and controls, however, 265 independent sites of statistically significant change between cases and controls were identified. Changed sites were found in genes associated with complexes I (30.2%), III (3.0%), IV (33.2%), and V (9.1%) as well as tRNA (10.6%) and rRNA (14.0%). Despite their statistical significance, the subtle nature of the observed changes makes it difficult to determine whether they represent true functional variants involved in AD etiology or merely naturally occurring dissimilarity. Regardless, this study demonstrates the tremendous value of this novel mtDNA resequencing platform, which avoids the pitfalls of erroneously amplifying nuclear-encoded mtDNA pseudogenes, and our proposed analysis paradigm, which utilizes the availability of raw signal intensity values for each of the four potential alleles to facilitate quantitative estimates of mtDNA heteroplasmy. This information provides a potential new target for burgeoning diagnostics and therapeutics that could truly assist those suffering from this devastating disorder.

Original languageEnglish (US)
Pages (from-to)194-210
Number of pages17
JournalMitochondrion
Volume6
Issue number4
DOIs
StatePublished - Aug 1 2006
Externally publishedYes

Fingerprint

Mitochondrial DNA
Alzheimer Disease
Pseudogenes
Population
Mutation
Transfer RNA
Oligonucleotide Array Sequence Analysis
Psychological Stress
Genes
Mitochondria
Blood Platelets
Alleles
Technology

Keywords

  • Alzheimer's disease
  • Heteroplasmy
  • Microarray
  • Mitochondria
  • Resequencing

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Cell Biology

Cite this

Coon, K. D., Valla, J., Szelinger, S., Schneider, L. E., Niedzielko, T. L., Brown, K. M., ... Stephan, D. A. (2006). Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. Mitochondrion, 6(4), 194-210. https://doi.org/10.1016/j.mito.2006.07.002

Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. / Coon, Keith D.; Valla, Jon; Szelinger, Szabolics; Schneider, Lonnie E.; Niedzielko, Tracy L.; Brown, Kevin M.; Pearson, John V.; Halperin, Rebecca; Dunckley, Travis; Papassotiropoulos, Andreas; Caselli, Richard J.; Reiman, Eric M.; Stephan, Dietrich A.

In: Mitochondrion, Vol. 6, No. 4, 01.08.2006, p. 194-210.

Research output: Contribution to journalArticle

Coon, KD, Valla, J, Szelinger, S, Schneider, LE, Niedzielko, TL, Brown, KM, Pearson, JV, Halperin, R, Dunckley, T, Papassotiropoulos, A, Caselli, RJ, Reiman, EM & Stephan, DA 2006, 'Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing', Mitochondrion, vol. 6, no. 4, pp. 194-210. https://doi.org/10.1016/j.mito.2006.07.002
Coon, Keith D. ; Valla, Jon ; Szelinger, Szabolics ; Schneider, Lonnie E. ; Niedzielko, Tracy L. ; Brown, Kevin M. ; Pearson, John V. ; Halperin, Rebecca ; Dunckley, Travis ; Papassotiropoulos, Andreas ; Caselli, Richard J. ; Reiman, Eric M. ; Stephan, Dietrich A. / Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing. In: Mitochondrion. 2006 ; Vol. 6, No. 4. pp. 194-210.
@article{0d9881f7d58140a28f3264e0bfcffb90,
title = "Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing",
abstract = "The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD) has been well documented. Though evidence for the role of mitochondria in AD seems incontrovertible, the impact of mitochondrial DNA (mtDNA) mutations in AD etiology remains controversial. Though mutations in mitochondrially encoded genes have repeatedly been implicated in the pathogenesis of AD, many of these studies have been plagued by lack of replication as well as potential contamination of nuclear-encoded mitochondrial pseudogenes. To assess the role of mtDNA mutations in the pathogenesis of AD, while avoiding the pitfalls of nuclear-encoded mitochondrial pseudogenes encountered in previous investigations and showcasing the benefits of a novel resequencing technology, we sequenced the entire coding region (15,452 bp) of mtDNA from 19 extremely well-characterized AD patients and 18 age-matched, unaffected controls utilizing a new, reliable, high-throughput array-based resequencing technique, the Human MitoChip. High-throughput, array-based DNA resequencing of the entire mtDNA coding region from platelets of 37 subjects revealed the presence of 208 loci displaying a total of 917 sequence variants. There were no statistically significant differences in overall mutational burden between cases and controls, however, 265 independent sites of statistically significant change between cases and controls were identified. Changed sites were found in genes associated with complexes I (30.2{\%}), III (3.0{\%}), IV (33.2{\%}), and V (9.1{\%}) as well as tRNA (10.6{\%}) and rRNA (14.0{\%}). Despite their statistical significance, the subtle nature of the observed changes makes it difficult to determine whether they represent true functional variants involved in AD etiology or merely naturally occurring dissimilarity. Regardless, this study demonstrates the tremendous value of this novel mtDNA resequencing platform, which avoids the pitfalls of erroneously amplifying nuclear-encoded mtDNA pseudogenes, and our proposed analysis paradigm, which utilizes the availability of raw signal intensity values for each of the four potential alleles to facilitate quantitative estimates of mtDNA heteroplasmy. This information provides a potential new target for burgeoning diagnostics and therapeutics that could truly assist those suffering from this devastating disorder.",
keywords = "Alzheimer's disease, Heteroplasmy, Microarray, Mitochondria, Resequencing",
author = "Coon, {Keith D.} and Jon Valla and Szabolics Szelinger and Schneider, {Lonnie E.} and Niedzielko, {Tracy L.} and Brown, {Kevin M.} and Pearson, {John V.} and Rebecca Halperin and Travis Dunckley and Andreas Papassotiropoulos and Caselli, {Richard J.} and Reiman, {Eric M.} and Stephan, {Dietrich A.}",
year = "2006",
month = "8",
day = "1",
doi = "10.1016/j.mito.2006.07.002",
language = "English (US)",
volume = "6",
pages = "194--210",
journal = "Mitochondrion",
issn = "1567-7249",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Quantitation of heteroplasmy of mtDNA sequence variants identified in a population of AD patients and controls by array-based resequencing

AU - Coon, Keith D.

AU - Valla, Jon

AU - Szelinger, Szabolics

AU - Schneider, Lonnie E.

AU - Niedzielko, Tracy L.

AU - Brown, Kevin M.

AU - Pearson, John V.

AU - Halperin, Rebecca

AU - Dunckley, Travis

AU - Papassotiropoulos, Andreas

AU - Caselli, Richard J.

AU - Reiman, Eric M.

AU - Stephan, Dietrich A.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD) has been well documented. Though evidence for the role of mitochondria in AD seems incontrovertible, the impact of mitochondrial DNA (mtDNA) mutations in AD etiology remains controversial. Though mutations in mitochondrially encoded genes have repeatedly been implicated in the pathogenesis of AD, many of these studies have been plagued by lack of replication as well as potential contamination of nuclear-encoded mitochondrial pseudogenes. To assess the role of mtDNA mutations in the pathogenesis of AD, while avoiding the pitfalls of nuclear-encoded mitochondrial pseudogenes encountered in previous investigations and showcasing the benefits of a novel resequencing technology, we sequenced the entire coding region (15,452 bp) of mtDNA from 19 extremely well-characterized AD patients and 18 age-matched, unaffected controls utilizing a new, reliable, high-throughput array-based resequencing technique, the Human MitoChip. High-throughput, array-based DNA resequencing of the entire mtDNA coding region from platelets of 37 subjects revealed the presence of 208 loci displaying a total of 917 sequence variants. There were no statistically significant differences in overall mutational burden between cases and controls, however, 265 independent sites of statistically significant change between cases and controls were identified. Changed sites were found in genes associated with complexes I (30.2%), III (3.0%), IV (33.2%), and V (9.1%) as well as tRNA (10.6%) and rRNA (14.0%). Despite their statistical significance, the subtle nature of the observed changes makes it difficult to determine whether they represent true functional variants involved in AD etiology or merely naturally occurring dissimilarity. Regardless, this study demonstrates the tremendous value of this novel mtDNA resequencing platform, which avoids the pitfalls of erroneously amplifying nuclear-encoded mtDNA pseudogenes, and our proposed analysis paradigm, which utilizes the availability of raw signal intensity values for each of the four potential alleles to facilitate quantitative estimates of mtDNA heteroplasmy. This information provides a potential new target for burgeoning diagnostics and therapeutics that could truly assist those suffering from this devastating disorder.

AB - The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease (AD) has been well documented. Though evidence for the role of mitochondria in AD seems incontrovertible, the impact of mitochondrial DNA (mtDNA) mutations in AD etiology remains controversial. Though mutations in mitochondrially encoded genes have repeatedly been implicated in the pathogenesis of AD, many of these studies have been plagued by lack of replication as well as potential contamination of nuclear-encoded mitochondrial pseudogenes. To assess the role of mtDNA mutations in the pathogenesis of AD, while avoiding the pitfalls of nuclear-encoded mitochondrial pseudogenes encountered in previous investigations and showcasing the benefits of a novel resequencing technology, we sequenced the entire coding region (15,452 bp) of mtDNA from 19 extremely well-characterized AD patients and 18 age-matched, unaffected controls utilizing a new, reliable, high-throughput array-based resequencing technique, the Human MitoChip. High-throughput, array-based DNA resequencing of the entire mtDNA coding region from platelets of 37 subjects revealed the presence of 208 loci displaying a total of 917 sequence variants. There were no statistically significant differences in overall mutational burden between cases and controls, however, 265 independent sites of statistically significant change between cases and controls were identified. Changed sites were found in genes associated with complexes I (30.2%), III (3.0%), IV (33.2%), and V (9.1%) as well as tRNA (10.6%) and rRNA (14.0%). Despite their statistical significance, the subtle nature of the observed changes makes it difficult to determine whether they represent true functional variants involved in AD etiology or merely naturally occurring dissimilarity. Regardless, this study demonstrates the tremendous value of this novel mtDNA resequencing platform, which avoids the pitfalls of erroneously amplifying nuclear-encoded mtDNA pseudogenes, and our proposed analysis paradigm, which utilizes the availability of raw signal intensity values for each of the four potential alleles to facilitate quantitative estimates of mtDNA heteroplasmy. This information provides a potential new target for burgeoning diagnostics and therapeutics that could truly assist those suffering from this devastating disorder.

KW - Alzheimer's disease

KW - Heteroplasmy

KW - Microarray

KW - Mitochondria

KW - Resequencing

UR - http://www.scopus.com/inward/record.url?scp=33748201067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748201067&partnerID=8YFLogxK

U2 - 10.1016/j.mito.2006.07.002

DO - 10.1016/j.mito.2006.07.002

M3 - Article

C2 - 16920408

AN - SCOPUS:33748201067

VL - 6

SP - 194

EP - 210

JO - Mitochondrion

JF - Mitochondrion

SN - 1567-7249

IS - 4

ER -